David A. Montecalvo - 22 Feb 2022 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Reporting relationship: SVP, Glob Ops and Supply Chain
Issuer ticker: WST
Reported as of: 22 Feb 2022
Net transaction value: +$1,327,761
SEC form: 4
Accepted by SEC: 24 Feb 2022, 20:25:28 UTC
Prior SEC filing: 14 Feb 2022
Source filing: View source filing
Reporting owner signature: Ryan Metz as Agent for David A. Montecalvo

Key filing fact

David A. Montecalvo filed Form 4 for WEST PHARMACEUTICAL SERVICES INC (WST) on 24 Feb 2022.

Key facts

This page summarizes David A. Montecalvo's Form 4 filing for WEST PHARMACEUTICAL SERVICES INC (WST).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Feb 2022, 20:25.

Change

Previous filing in this sequence was filed on 14 Feb 2022.
Current net transaction value: +$1,327,761.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WST transaction

Common Stock

Award

Transaction value: $1,327,761
Shares: +3,597
Change %: +35%
Price: $369.13
Shares after: 13,731
Date: 22 Feb 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

2019 PSUs (PP18) award vesting net of taxes withheld. The net shares were deferred as deferred stock units in the Non-Qualified Deferred Compensation (NQDC) plan for employees to be distributed in accordance with the terms of the NQDC plan and their individual elections